Debut Plus

₹1,649.2

▲ +9.18 +0.56%

17 Jul 2026

NSE Listed · Pharmaceuticals

Onesource Specl Pharma Limited (ONESOURCE)

Volume: 53,125Avg Vol 1W: 1,01,209Avg Vol 1M: 2,03,12152W Range:₹1,057₹2,088
NSE BSE www.onesourcecdmo.com
Key Ratios
Checked 11h ago
Market Cap₹18,907 Cr
Current Price₹1,649.2
Previous Close₹1,640.02
High / Low (52w)₹2,088 / ₹1,057
Volume53,125
Avg Vol (1W)1,01,209
Avg Vol (1M)2,03,121
Stock P/E4,089
Book Value₹508.64
Dividend Yield0%
ROE-109.95%
ROA-89.89%
Revenue (TTM)—
Revenue Growth7.4%
Profit Margin-5.19%
Total Debt₹219 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹0
P/B3.24
Debt / Equity0.26
50 DMA₹1,627.53
200 DMA₹1,598.37
Day change+0.56%
Price Chart
₹1,649.2▲ 1.10% · 1Y
₹1876₹111145.3L
2025-11-21
2026-07-16

20-day avg volume: 2.2L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 730% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 4089.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹292 Cr₹334 Cr₹393 Cr₹426 Cr₹327 Cr₹376 Cr₹290 Cr₹428 Cr
EBITDA₹0 Cr₹13 Cr₹80 Cr₹117 Cr₹26 Cr₹40 Cr₹-48 Cr₹22 Cr
Net Profit₹-6 Cr₹-42 Cr₹-69 Cr₹99 Cr₹0 Cr₹10 Cr₹-89 Cr₹5 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹2 Cr₹22 Cr₹136 Cr₹41 Cr₹176 Cr₹1,462 Cr
EBITDA₹-112 Cr₹-105 Cr₹-163 Cr₹-224 Cr₹-160 Cr₹210 Cr
Net Profit₹-140 Cr₹-121 Cr₹-231 Cr₹-800 Cr₹-391 Cr₹-18 Cr
EPS-1,891.41-66.65-65.25-200.87-94.15-1.63
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹971 Cr₹1,258 Cr₹2,442 Cr₹2,009 Cr₹1,309 Cr₹7,550 Cr
Total Liabilities₹554 Cr₹482 Cr₹1,430 Cr₹1,223 Cr₹913 Cr₹1,670 Cr
Equity₹417 Cr₹776 Cr₹1,012 Cr₹785 Cr₹396 Cr₹5,881 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-52 Cr₹-117 Cr₹-416 Cr₹-174 Cr₹-107 Cr₹-61 Cr
Investing₹-157 Cr₹-207 Cr₹-692 Cr₹-68 Cr₹511 Cr₹-201 Cr
Financing₹65 Cr₹381 Cr₹1,162 Cr₹118 Cr₹-391 Cr₹412 Cr
Free Cash Flow₹-52 Cr₹-117 Cr₹-416 Cr₹-218 Cr₹-171 Cr₹-189 Cr
Shareholding
Promoter 30.48% Institutions 38.11% Public 31.41%
Efficiency & Working Capital
ROCE0.5%
Interest Coverage1.3
Dividend Payout—
Debtor Days105 d
Inventory Days40 d
Payable Days44 d
Cash Conversion Cycle101 d
Working Capital Days145 d
Shareholding Details

As of 2026-03-31

Promoter30.5%
FII17.5%
DII20.6%
Institutions38.1%
Public31.4%
Promoter Pledge38.4%
No. of Shareholders79,460
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters37.8%34.3%29.8%29.8%29.9%30.5%
FIIs17.4%18.5%18.7%19.4%19.2%17.5%
DIIs12.6%18%18.1%18.5%18.8%20.6%
Public32.2%29.2%33.4%32.4%32%31.4%
Promoter Pledge9.6%20.1%25%26%18.5%38.4%
No. of Shareholders98,42582,71287,76087,41684,59579,460
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Tenshi Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group18.4%2.11 Cr
Karuna Business Solutions LlpShareholding of Promoter and Promoter Group7.1%80,90,353
Authum Investment And Infrastructure LimitedPublic Shareholding5.2%59,09,646
Motilal Oswal Mutual FundPublic Shareholding5%57,25,194
Amansa Holdings Private LimitedPublic Shareholding3.5%39,73,201
Sbi Life Insurance Co LtdPublic Shareholding2.5%29,02,874
Pronomz Ventures LlpShareholding of Promoter and Promoter Group2.4%27,61,308
Route One Offshore Master Fund L.p.Public Shareholding2.3%26,63,310
Timf HoldingsPublic Shareholding2.2%25,16,700
Route One Fund I, L.p.Public Shareholding2.1%23,68,534
Think Investments PccPublic Shareholding1.8%20,49,497
360 One Special Opportunities Fund - Series 12Public Shareholding1.6%18,52,688
Arco Lab Private LimitedShareholding of Promoter and Promoter Group1.6%18,39,900
Axis Mutual FundPublic Shareholding1.5%16,83,965
Mirae AssetPublic Shareholding1.2%13,97,805
Arun Kumar PillaiShareholding of Promoter and Promoter Group0.9%9,70,497
Padmakumar Karunakaran PillaiShareholding of Promoter and Promoter Group0%43,242
Vineetha Mohanakumar PillaiShareholding of Promoter and Promoter Group0%47,500
Rajitha GopalakrishnanShareholding of Promoter and Promoter Group0%30,000
Sajitha PillaiShareholding of Promoter and Promoter Group0%35,000
Aditya Arun KumarShareholding of Promoter and Promoter Group0%29,211
Hemalatha PillaiShareholding of Promoter and Promoter Group0%3,380
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Arun Kumar Pillai00%2026-03-31
Aditya Arun Kumar00%2026-03-31
Hemalatha Pillai00%2026-03-31
Padmakumar Karunakaran Pillai00%2026-03-31
Rajitha Gopalakrishnan00%2026-03-31
Sajitha Pillai00%2026-03-31
Vineetha Mohanakumar Pillai00%2026-03-31
Karuna Business Solutions Llp3,00,0003.7%2026-03-31
Tenshi Pharmaceuticals Private Limited1.29 Cr61.2%2026-03-31
Pronomz Ventures Llp2,07,2047.5%2026-03-31
Arco Lab Private Limited00%2026-03-31
Axis Mutual Fund00%2026-03-31
Board of Directors
NameDesignationYear
Arun KumarChairman & Non Executive Dir.2025
Neeraj SharmaManaging Director & CEO2025
Debarati SenIndependent Non Exe. Director2025
Claudio AlbrechtIndependent Non Exe. Director2025
Rashmi Harshadrai BarbhaiyaIndependent Non Exe. Director2025
Vijay Paul KarwalIndependent Non Exe. Director2025
Colin Michael BondIndependent Non Exe. Director2025
Bharat ShahNon Executive Director2025
Trisha ACompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
CDMO₹1,300 Cr100%
Unit 3 : Multimodal facility and CD₹0 Cr0%
Segments — Geography
RegionRevenueShare
India₹194 Cr14.9%
Singapore₹668 Cr51.4%
Outside India₹438 Cr33.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1151111
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20251,0180095771,604
2025110006778
2025360009382751
Insider / Designated-Person Trades

17 recent disclosure(s)

Tenshi Pharmaceuticals Private LimitedAcquisition · 2,00,000
TENSHI PHARMACEUTICALS PRIVATE LIMITEDAcquisition · 85,000
TENSHI PHARMACEUTICALS PRIVATE LIMITEDAcquisition · 75,000
TENSHI PHARMACEUTICALS PRIVATE LIMITEDAcquisition · 2,05,000
PRONOMZ VENTURES LLPAcquisition · 45,000
PRONOMZ VENTURES LLPAcquisition · 33,906
Substantial Acquisitions (SAST)

8 disclosure(s)

Market04/02/2026 · 85,000
Market02/02/2026 · 2,05,000
Market02/02/2026 · 45,000
Market30/01/2026 · 75,000
Market30/01/2026 · 33,906
Market28/01/2026 · 2,00,000
Company Information
Incorporated2007
ChairmanArun Kumar
AuditorDeloitte Haskins & Sells/BSR & Co LLP
Investor Email[email protected]
🌐 www.onesourcecdmo.com ↗

📍 201 Devarata Sector 17 Vashi, Navi Mumbai Sanpada, Thane, Maharashtra, 400703

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Om Infra LimitedOmnitech Engineering Ltd.Om Power Transmission Ltd.On Door Concepts LimitedOnelife Cap Advisors Ltd.One Point One Sol Ltd.Oil And Natural Gas Corp.OnMobile Global Ltd.Onward Technologies Ltd.Onyx Biotec LimitedOptiemus Infracom Ltd.Optivalue Tek Consult Ltd.All “O” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search